Aurora Diagnostics Acquires University Pathologists
Aurora Diagnostics has announced the acquisition of University Pathologists, including its affiliated technical lab, University Pathologists Diagnostics.
University Pathologists, based in Warwick, R.I., provides hospital-based professional anatomic pathology services to eight hospitals affiliated with several systems and – through its technical lab in Fall River, Mass. – to various physician practices in Connecticut, Massachusetts and Rhode Island.
“We welcome the highly regarded pathologists and lab professionals of University Pathologists to Aurora Diagnostics,” said Daniel D. Crowley, Chairman and Chief Executive Officer of Aurora. “University Pathologists and its lab are known for providing excellent pathology services, and we look forward to serving the region with them.”
“Aurora has a strong focus on quality, service and local community relationships – values that we share – making this an excellent strategic partner for our organization,” said Dr. Jila Khorsand, Managing Director of University Pathologists. “We are very pleased to be part of this growing company.”
Other Aurora Diagnostics locations in New England include DermDX in Boston, Hallmark Pathology in Medford, Mass., and Seacoast Pathology in Exeter, N.H.
This acquisition is Aurora’s tenth acquisition overall and eighth in the hospital laboratory sector since 2013. Serving more than 100 hospitals throughout the U.S., Aurora Diagnostics is a leader in providing hospital lab management services.
Additionally, its Aurora Research Institute subsidiary is a leader in helping hospitals and independent labs to ethically provide tissue and blood samples to researchers on the cutting edge of research for effective cancer treatments.
“We continue to expand our capabilities as we serve the needs of physicians and hospitals in the rapidly changing healthcare environment,” said Mr. Crowley. Terms of the transaction were not disclosed.
Mass General, Brigham and Women's, Philips Collaborate to Advance Digital Pathology AdoptionNews
Leveraging Philips’ comprehensive portfolio of advanced digital pathology solutions, MGH and BWH aim to deploy digital pathology infrastructures to enable digital pathology research, education and collaboration and to help shape and inform the deployment of digital pathology across the country by establishing best practices and protocols.READ MORE
Cancer ‘Signature’ First Step Toward Blood Test for PatientsNews
A discovery by Melbourne researchers could help to identify patients with a particularly aggressive type of lung cancer that are likely to respond to immunotherapies currently used in the clinic to treat other cancers.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE
Comments | 0 ADD COMMENT
The Journey from Genes to Disease - a symposium for postdocs by postdocs.
Apr 20 - Apr 20, 2018